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Abstract
Background:  The collection of information on infertility treatments is important for the
surveillance of potential health consequences and to monitor service provision.
Study design: We compared the coverage and outcomes of IVF children reported in aggregated
IVF statistics, the Medical Birth Register (subsequently: MBR) and research data based on
reimbursements for IVF treatments in Finland in 1996–1998.
Results: The number of newborns were nearly equal in the three data sources (N = 4331–4384),
but the linkage between the MBR and the research data revealed that almost 40% of the reported
IVF children were not the same individuals. The perinatal outcomes in the three data sources were
similar, excluding the much lower incidence of major congenital anomalies in the IVF statistics (157/
10 000 newborns) compared to other sources (409–422/10 000 newborns).
Conclusion: The differences in perinatal outcomes in the three data sets were in general minor,
which suggests that the observed non-recording in the MBR is most likely unbiased.
Background
IVF services and children born as a result of IVF treatments
have been monitored carefully due to the ethical, legal
and economic aspects of assisted reproduction and due to
the suggested health risks for treated women and IVF chil-
dren. In this article we define IVF to include classical IVF,
its modifications (mainly ICSI) and frozen embryo trans-
fers (FETs).
Information on IVF treatments and their outcomes has
been gathered by three methods: 1) the collection of
aggregated, statistical information on the number of treat-
ments and their results, 2) the collection of individual-
level information on all IVF treatments and their results,
and 3) the collection of individual-level information on
all children born as a result of IVF treatments [1]. The
European reporting systems have been varyingly adminis-
tered, most often by a health authority, an independent
official body, or an association, typically a national fertil-
ity society. No routine monitoring system exists in some
countries, but ad hoc data collection from IVF clinics has
been used to obtain data for international comparisons
[1].
In Finland, health authorities have used the two methods
to monitor IVF. First, information on all successful IVF
treatments, i.e. those leading to births and newborns, has
been gathered since October 1990 in the Medical Birth
Register (subsequently: MBR), which is one of the manda-
tory health registers. Second, aggregated IVF statistics
based on initiated treatment cycles have been gathered
since January 1992 [2,3]. Both existing data sources have
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their limitations. The MBR does not include information
on women whose treatment did not result in a birth.
Aggregated IVF statistics do not enable background-
adjusted comparisons between clinics, studies on the use
and accumulation of services at individual level, or the
follow-up of women or newborns after the perinatal
period.
The main requirements for the use of administrative
health registers are that they be complete and that their
content corresponds to reality [4]. Even though many
Finnish health registers have been shown to have high
completeness and validity [4,5], the case may be different
for relatively rare events such as infertility treatments. A
previous study suggested that information on IVF treat-
ments in the MBR is missing for 15% of IVF children [6].
Reasons may include problems in distinguishing between
different infertility treatments when filling in the data col-
lection form in the delivery hospitals; a lack of data in
pregnancy records; or mothers' wishes to conceal their uti-
lisation of infertility treatments. The validity of Finnish
IVF statistics has not been evaluated.
To estimate the completeness and validity of the two rou-
tinely collected data bases – MBR and IVF statistics – we
compared their information to ad hoc research data for
the period 1996 to 1998. The ad hoc data set was created
for research purposes by using information on reimburse-
ments for health care services and prescriptions. The main
focus of this study was the newborn outcomes of IVF chil-
dren, since there was extensive information on this subject
in all data sources.
Methods
IVF statistics
The collection of Finnish IVF statistics was started in 1992
on the initiative of the Finnish Society of Obstetrics and
Gynecology. Since 1994, STAKES (National Research and
Development Centre for Welfare and Health) has had
responsibility for data compilation. The data collection is
voluntary and is based on aggregated data on initiated IVF
treatments [3]. All clinics participate in the data collec-
tion. Since 1994 the data has been collected by using the
international data collection form and definitions recom-
mended by the International Working Group for Registers
on Assisted Reproduction [7]. The form includes ques-
tions on the number of treatments, on the age of the
treated women and their cause of infertility, on the
number of transferred embryos, on the results of transfers
(number of clinical pregnancies, miscarriages, ectopic
pregnancies, induced abortions, stillbirths, live births,
gestational age) and on newborn outcomes (birth weight,
perinatal mortality and congenital anomalies) [3].
Medical Birth Register (MBR)
The MBR was started in 1987, and is run by STAKES. The
register includes the mother's and child's unique, personal
identification numbers, and it collects information on
maternal background, on care and interventions during
pregnancy and delivery and on the newborn's outcome up
until the age of seven days. Data are compiled at the time
of birth, using mothers' prenatal cards as one of the infor-
mation sources. The information on IVF (defined as IVF,
ICSI, FETs and equivalent treatments in the MBR instruc-
tions) has been collected since October 1990. Addition-
ally, since 1996, information on both IVF and other
assisted reproduction (defined as insemination, ovulation
induction and equivalent treatments) has been collected.
Data linkage between the MBR data and the IVF research
data (see later) showed that items referring to IVF and
'other assisted reproduction' could not be separated in the
MBR, and the majority of children born after 'other
assisted reproduction' were in fact born as a results of IVF.
Thus the two items were merged in this study.
The MBR data are collected from all delivery hospitals and
in the case of home births is collected by the assisting
health care personnel [2]. Less than 1% of all newborns
are missing from the MBR; information on them can be
obtained by making data linkages to the Central Popula-
tion Register and the Cause-of-Death Register kept by Sta-
tistics Finland, but no medical information, including
information on IVF, is available for these births. After this
data linkage the MBR is considered to be complete in
terms of numbers of births and newborns. According to
two data quality studies, the majority of the MBR content
corresponds well or satisfactorily with hospital records
[2,8].
The MBR data are based on the year of birth, while the
other data sources are based on the date of conception.
Therefore, the date of conception was calculated for all IVF
newborns in the MBR by using the date of birth and the
information on the best estimate of the gestational age
[9].
Ad hoc research data
For research purposes data on IVF treatment cycles and
other infertility treatments (including ovulation induc-
tions) performed in the 1996–1998 period were collected
from national insurance reimbursement files [10]. The
first data source was information on reimbursed costs for
private health care services including physicians' consulta-
tions, laboratory and radiological examinations, and
infertility treatment procedures. Private services provide
some 60% of initiated IVF treatments in Finland [3]. The
reimbursements are based on physicians' itemised bills,
and they are filed at the National Social InsuranceBMC Medical Informatics and Decision Making 2004, 4 http://www.biomedcentral.com/1472-6947/4/3
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Institution in an electronic register under women's per-
sonal identification numbers.
The second source was information on drugs prescribed
by physicians in outpatient care, covering both the public
and private sectors. The National Social Insurance Institu-
tion reimburses all drug prescriptions for IVF, and it has
kept records on reimbursed prescriptions in an electronic
register since 1996. The data includes the woman's per-
sonal identification number, municipality of residence,
name and class of the drug prescribed, the size and num-
bers of packages, the recommended dose, the dates pre-
scribed and bought, and the code of the prescribing
physician. Information on the indication is not recorded.
An algorithm, based on theoretical rules on the use of
drugs specific to infertility treatments and their combina-
tions, sequence and dosages, was created to classify
women into two groups: women receiving IVF treatments
and women receiving other ovulation inductions [10].
In order to find births resulting from infertility treatments,
information on treatments undertaken was linked to the
MBR. Exact dates of treatments were not available, so we
used the time difference between the beginning of the last
treatment cycle and the birth of the child to estimate
which births resulted from IVF or ovulation induction,
and which births were the results of spontaneous concep-
tion. The time limit of 44 weeks was used as a standard,
but another limit of 72 weeks (subsequently: loose defini-
tion) was utilised to take into account the uncertainty
caused by missing information on exact treatment dates.
Congenital anomalies
In the IVF statistics, a short description of each major con-
genital anomaly – excluding e.g. minor birthmarks of the
skin, postural talipes, or clicky hips – leading to a selective
induced abortion or to a birth is requested from all IVF
clinics. The reported congenital anomalies are reviewed
by a clinical expert, and all minor anomalies or outcomes
other than congenital anomalies are removed from the
statistics. Since the other two data sources did not include
information on induced abortions, only congenital
anomalies among stillbirths and live births were included
in our comparisons. The MBR and the IVF research data
were combined with the Finnish Register of Congenital
Malformations (subsequently: Malformation Register) by
using mothers' personal identification numbers and the
dates of birth, and its definitions and classifications were
used (see: Definitions). The Malformation Register col-
lects information on all newborns with a congenital
anomaly or birth defect through several data sources,
including a special data collection form completed by
delivery hospitals, and diagnosis data from the MBR, from
the Hospital Discharge Register, from the Cause-of-Death
Register and from cytogenetic laboratories until the age of
one year.
Definitions
The definition of stillbirth was the same in the MBR and
in the IVF research data (a gestational age of 22 weeks or
more or a birth weight of 500 grams or more), but was
found to be looser in the IVF statistics (gestational age of
20 weeks or more). The same definition of SGA (small-
for-gestational age), based on national standards given by
Pihkala et al. [11], was utilised in the MBR and in the IVF
research data. The Malformation Register defines a major
congenital anomaly as a significant congenital structural
anomaly, chromosomal defect or congenital hypothy-
roidism. This does not include hereditary diseases and
other diseases not associated with congenital anomalies,
dysfunction of organs or tissues, developmental disabili-
ties, congenital infections, isolated minor dysmorphic fea-
tures, normal variations and common less significant
congenital anomalies, which are on the exclusion list uti-
lised by the Malformation Register. The exclusion list for
minor congenital anomalies is comparable to the list
which is utilised by the European Surveillance of Congen-
ital Anomalies EUROCAT [12].
Data analysis
The comparison of information in the IVF statistics with
other sources could only be performed on an aggregated
level, since this data source contains no personal-level
data. The MBR data and the IVF research data were com-
pared at an individual level using women's unique per-
sonal identification numbers as the linkage key. The
statistical comparisons were done using the chi-square
test, the t-test, the test for relative proportions, Fischer's
exact test and κ-statistics.
Data protection issues
According to national data protection legislation, a lim-
ited number of health registers – including the MBR – can
be collected using the personal identification number.
Since compilation of IVF data is not included in these stat-
ues, only aggregated data can be collected without
informed consent from each patient. The ad hoc research
data was received from the Social Insurance Institution
after a special permission for its use in scientific research
was given. The data linkage between this data and the
MBR was performed after the register keeping organisa-
tions and the National Data Protection Authority had
authorised it.
Results
The number of initiated cycles was 16% higher and the
number of transfers 3% higher in the IVF research data
than in the IVF statistics. The number of births was almost
equal in all data sets. The proportion of multiple birthsBMC Medical Informatics and Decision Making 2004, 4 http://www.biomedcentral.com/1472-6947/4/3
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varied between 22% and 23%, and all these differences
between the three data sets were statistically insignificant.
The variation in the number of newborns followed the
same pattern as observed for births. There were, however,
more IVF triplets in the MBR (2.1% of all births) than in
the IVF statistics (1.0%; p < 0.001) and in the IVF research
data (1.1%; p < 0.001) (Table 1). We also performed all
analyses using a looser definition for IVF in the ad hoc
research data. This gave 3876 births and 4680 newborns,
which respectively were 7.8% and 6.8% higher than the
number received by using the strict definition. When com-
paring the two definitions, the proportion of multiples
was somewhat lower (20.3%, p = 0.190) than that deter-
mined using the strict definition, but no statistically sig-
nificant differences were found.
The data linkage between the MBR and the IVF research
data indicated a substantial general concordance of the
IVF item in these two data sources: the proportion of chil-
dren with a correctly reported IVF status (yes/no) was
98.7% and κ-statistics 0.75 (95% confidence interval:
0.74–0.76). If only IVF children were included in the anal-
ysis, the quality was poorer: the percentage of children
with a correctly reported IVF status declined substantially
to 60.2%. The individual linkage revealed, that 24.8% of
IVF children (N = 1088) identified in the IVF research data
lacked IVF information in the MBR, but on the other hand
24.8% of IVF children (N = 1087) in the MBR were not
found in the IVF research data. Thus, even though the total
numbers were very similar, 39.8% of children reported to
the two data sources as IVF children were different chil-
dren (Table 2). These results did not vary by maternal age,
parity, maternal smoking and perinatal outcome (data
not shown).
Identical κ-statistics were received when using the loose
definition, but the proportion of correctly reported IVF
children decreased to 59.0%. The proportion of IVF chil-
dren in the IVF research data for whom IVF information
was lacking in the MBR increased to 28.2%, and the pro-
portion of IVF children in the MBR who were not identi-
fied in the IVF research data decreased to 23.3%.
Age distributions of women with initiated cycles could be
determined from the IVF statistics (excluding FETs) and
from the IVF research data. The age distributions were
similar (data not shown). Also the proportion of women
aged less than 25 years (2.3% vs. 2.5%, p = 0.151) and the
proportion of women aged 35 years or more (43% vs.
44%, p = 0.226) were similar.
Table 1: Number of IVF treatments and outcomes according to three data sources, Finland 1996–1998.
IVF statistics MBR1) IVF research data
Number of treated women n.a. n.a. 9175
Number of treatments 20 912 n.a. 24 318
Number of transfers 18 750 n.a. 19 246
Number of clinical pregnancies 4770 n.a. n.a.
Lost of follow-up 112 n.a. n.a.
Number of births 3535 3557 3594
- of which multiples, % 22.6 22.3 21.6
Number of newborns 4331 4383 4384
- of which twins, % 35.9 34.6 34.6
- of which triplets, % 1.0 2.1 1.1
1) MBR = Medical Birth Register. n.a. = not available
Table 2: Data linkage between the MBR (N = 176 698) and the IVF research data (N = 8651), Finland, 1996–1998.
MBR
IVF Other Total
IVF research data IVF 3296 1088 4384
Other OI1) 493 3774 4267
Not in data 594 167 453 168 047
Total 4383 172 315 176 698
OI = Ovulation induction.BMC Medical Informatics and Decision Making 2004, 4 http://www.biomedcentral.com/1472-6947/4/3
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Information on the backgrounds of parturients was avail-
able from the MBR and from the IVF research data. The
mean maternal age was some three months lower in the
MBR (p = 0.005), and the proportions of mothers aged 35
years or more (37% in the MBR and 40% in IVF research
data, p = 0.053) and of mothers aged 40 years or more (8
and 10%, respectively, p = 0.002) were lower in the MBR
than in the IVF research data. There were fewer single IVF
mothers in the MBR (3%) than in the IVF research data
(4%) (p = 0.023). The distributions of socioeconomic
position differed between the MBR and the IVF research
(p < 0.001), but this difference disappeared after those
with an undefined socioeconomic position were excluded
from the analysis (p = 0.357). There were small differ-
ences in parturients' residence: the MBR reported more
IVF in south-east Finland, but less in southern Finland
(including the capital area) and in central Finland than
did the IVF research data (data not shown). The differ-
ences in the number of previous pregnancies and births
and in maternal smoking were minor (Table 3).
All three data sources showed more perinatal health prob-
lems for IVF children compared to all children born in the
study period. With the exception of congenital anomalies,
the infant outcomes were similar in all three IVF data sets
(Table 4). The incidence of premature births varied from
17% to 18%, the incidence of low birth weight from 19%
to 21%, the incidence of SGA from 6.9% to 7.0%, and the
perinatal mortality rate from 12 per 1000 to 14 per 1000.
None of the differences were statistically significant. The
same was true for differences among singletons, but
among multiples the MBR reported more premature
births than did the IVF statistics (49% vs. 43%, p = 0.019)
and the MBR indicated more low birth-weight children
than did the IVF research data (46% vs. 43%, p = 0.013)
or the IVF statistics (46% vs. 42%, p = 0.002) as a conse-
quence of the excess number of triplets.
The IVF statistics indicated that there were 157 major con-
genital anomalies per 10 000 newborns. The incidences
were much higher in the MBR (422/10 000 newborns, p <
0.001) and in the IVF research data (409/10 000 new-
borns, p < 0.001), but the difference between the figure
from the MBR and the IVF research data was not statisti-
cally significant (p = 0.373) (Table 4). Similar underre-
porting in the IVF statistics was also observed, when
Table 3: Background characteristics of IVF mothers in the MBR and in the IVF research data, Finland 1996–1998, %1)
MBR IVF research data p
Deliveries 3557 3594
Age at birth, years 0.029
Less than 25 years 2.9 2,9
25–29 19.0 17.3
30–34 40.7 40.7
35–39 29.4 29.4
40 or more 8.1 9.7
Mean age 33.6 33.9 0.005
SD 4.5 4.5
Single mother 3.8 2.9 0.024
Number of previous pregnancies 0.744
05 0 . 0 4 9 . 5
12 6 . 1 2 6 . 3
21 2 . 4 1 2 . 0
3 or more 11.5 12.2
Number of previous births 0.299
07 0 . 8 7 2 . 0
12 2 . 0 2 1 . 4
2 5.1 4.3
3 or more 2.1 2.3
Smoked during pregnancy 7.1 6.5 0.339
Socioeconomic position < 0.001
Upper white-collar 24.9 26.7
Lower white-collar 48.7 49.6
Blue-collar 13.3 14.9
Other2) 13.1 8.8
1) No information available in the IVF statistics. 2) Including entrepreneurs, farmers, students, unemployed, retired, housewives and others for 
whom no social class could be stated.BMC Medical Informatics and Decision Making 2004, 4 http://www.biomedcentral.com/1472-6947/4/3
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studying some single major congenital anomalies, which
can be observed at birth, such as trisomy 21 (9.2/10 000
newborns compared to 15.4/10 000 newborns in the IVF
research data, p = 0.206), cleft palates (6.9/10 000 vs.
37.3/10 000, p = 0.001), and neural tube defects (2.3/10
000 vs. 11.0/10 000, p = 0.058).
Discussion
Poor perinatal outcomes of IVF children may be caused by
higher multiplicity rate, adverse results of IVF technology,
or infertility. Previous Finnish research on IVF children
has shown that the main cause of increased perinatal
health problems is multiplicity, but even IVF singletons
have a higher risk for adverse perinatal outcomes than did
singletons in general [6,13-16]. These studies have had
uncertainties, such as unclear coverage [6,14] and small
sample size [15,16]. This study comparing three different
nation-wide data sources suggests that poorer perinatal
outcomes are unlikely to be due to methodological
problems.
Our data showed that the existing two IVF data sets –
aggregated data from clinics and individual-level data on
newborns – gave short-term outcomes largely identical to
those found in the ad hoc IVF research data, with the
exception of congenital anomalies. The data linkage
between the MBR and the IVF research data revealed, how-
ever, that up to two out of five IVF children were not the
same individual children. This discrepancy can be
explained by the problems in getting information on IVF
entered into the MBR; by the problems in forming the IVF
research data; and by the differences in the methods used
to compile the data sets and in their inclusion criteria.
For one in four IVF children the information on IVF was
missing in the MBR. We can suggest three reasons for this.
First, there may be difficulties in distinguishing between
IVF and other assisted reproduction methods in the
maternity hospitals. A closer analysis of the MBR data
showed that there were several large hospitals which did
not report any IVF but only other assisted reproduction.
This suggests that the hospital computer programs were
Table 4: Perinatal outcome by the three data sources, Finland 1996–1998, %1)
MBR IVF statistics IVF research data
Births 3535 3557 3594
- singletons 2735 2765 2819
- multiples 800 792 775
Premature births (< 37 weeks), N 582 623 634
% 16.5 17.5 17.6
- among singletons 8.7 8.5 9.4
- among multiples 43.1 49.0 47.7
Newborns 4331 4383 4384
- singletons 2735 2765 2819
- multiples 1596 1618 1565
Low birth weight (< 2500 grams), N 836 906 856
% 19.3 20.7 19.5
- among singletons 6.0 5.9 6.4
- among multiples 42.2 46.2 43.1
Small-for-gestational age, N n.a. 301 305
% n.a. 6.9 7.0
- among singletons n.a. 2.4 3.1
- among multiples n.a. 15.4 14.4
Birth weight, g
Mean (SD) n.a. 3085 (787) 3090 (781)
- among singletons n.a. 3440 (625) 3421 (644)
- among multiples n.a. 2475 (650) 2494 (640)
Perinatal mortality, N 61 54 56
per 1000 newborns 14.1 12.3 12.8
- among singletons 8.8 8.3 8.5
- among multiples 23.8 20.4 21.1
Major congenital anomaly cases, N 68 185 179
per 10 000 newborns 157 422 409
1) The following comparisons are statistically significant: - IVF statistics vs. MBR: Premature births among multiples P = 0.019. Low birth-weight 
among multiples P = 0.002. Major congenital anomaly cases P < 0.001. - IVF statistics vs. IVF research data: Major congenital anomaly cases P < 
0.001. - MBR vs. IVF research data: Low birth-weight among multiples P = 0.013. n.a. = not availableBMC Medical Informatics and Decision Making 2004, 4 http://www.biomedcentral.com/1472-6947/4/3
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not updated when the last revision was made to the MBR
data collection form in 1996. Therefore, we had to include
all children born as a result of assisted reproduction in the
IVF group, even though some (at maximum 11%) were
not IVF children. This approach accounts for 45% of those
"extra" IVF children in the MBR who were not identified
as IVF children in the research data. Second, information
on the use of infertility treatments may not reach the
maternity hospitals. Creating a seamless exchange of
information between IVF clinics, antenatal care clinics
and maternal hospitals would solve the problem. On the
other hand, some women may also be deliberately
excluded if the patient has decided to conceal their use of
infertility treatments. Third, the formation of the IVF
research data was based on administrative register data,
which may include incorrect entries, for example, in the
drug information or in the treatment codes. This would
mean that the IVF research data includes women who did
not use IVF, and the missing information on IVF in the
MBR is actually correct.
On the other hand, one in four children reported to be IVF
children in the MBR were not found in the IVF research
data. Three reasons may explain this. First, there is the
problem of wrongly classifying a child as an IVF child in
the MBR. Second, the algorithm in the research data was
based on current knowledge on drugs used in IVF treat-
ments, but the same drugs may be used for other pur-
poses. We were conservative in defining IVF cases to avoid
false negative cases, and may therefore have excluded
women who actually had received IVF. Third, it is possible
that the IVF research data missed some women who had
been treated in the public sector and who had used drugs
which were bought and reimbursed earlier to reach the
annual ceiling for free medication [17].
Besides these main explanatory factors, a small part of the
discordance may be explained by technical factors.
Despite the large number of possible sources of bias, their
effect on our results and conclusions was estimated to be
negligible. First, the study period was defined from the
start of treatment in the IVF statistics and in the IVF
research data, but was retrospectively determined from
the date of conception in the MBR. Second, IVF statistics
lacked information on some of the less frequent treat-
ments, such as oocyte donation and assisted hatching.
Third, the inclusion criteria differed for foreigners; they
were included in the IVF statistics, but not in the MBR or
in the IVF research data. Private Finnish IVF clinics pro-
vide treatments which are unavailable in some neighbour-
ing countries, such as the use of donated oocytes, and the
treatment of single women and lesbian couples. On the
other hand, Finnish women who received IVF services in
other countries – for example in Estonia due to more inex-
pensive treatments – cannot be found in IVF statistics of
the IVF research data, but they were included in the MBR
if their births occurred in Finland. Fourth, women who
were entitled to reimbursements but who did not apply
for them were not in the IVF research data, but were in the
two other sources. This group is assumed to be small,
because drugs and treatments are expensive, and the reim-
bursement is usually already given in the IVF clinic and in
the pharmacy. Fifth, the IVF statistics included all preg-
nancies after 20 weeks of gestation, while the MBR and the
IVF research data included births after 22 weeks of gesta-
tion [18].
More triplets were reported to the MBR than found in the
IVF statistics or in the ad hoc IVF register data. We have no
clear explanation for this phenomenon. It may be caused
by the fact that the MBR data is collected in the delivery
hospitals, and naturally conceived triplets may incorrectly
be assumed to have resulted from infertility treatments.
Another explanation is that Finnish women who were
treated in the neighboring countries more commonly
using three occytes or more per transfer gave triplet births
in Finland. The most likely explanation, however, is our
decision to define all children reported to have resulted
from IVF or other assisted reproduction techniques as IVF
children due to quality problems in the MBR: some tri-
plets may have resulted from ovulation induction.
With the exception of major congenital anomalies the
infant outcomes were similar by data source. It seems that
information on congenital anomalies does not reach the
IVF clinics, or the received information may be too inac-
curate to confirm whether the congenital anomaly is a
major one or not. This is also confirmed by recent studies
on the connection between IVF and congenital anomalies:
Lower proportions of children with major congenital
anomalies have been reported in studies based on data
collected routinely from IVF clinics, from 2.0% to 3.2% of
children [19,20], than in special studies using data link-
ages to birth and malformation registers [21-24], from
4.8% to 9.0%.
A different follow-up period (one year in the Malforma-
tion Register and undefined in the IVF statistics) can
explain part of the discrepancy. The monitoring of
congenital anomalies related to IVF is important, since
previous studies [15,16,21,24] have reported a higher
incidence of certain anomalies among IVF children. In
this study the incidences of major congenital anomalies in
the MBR and in the IVF research data were also higher
than that observed for the general population (288/10
000 newborns). The cases of congenital anomalies found
in this study will be investigated further with an adequate
control group. For this kind of study, it is essential that the
Malformation Register or other data sources which can beBMC Medical Informatics and Decision Making 2004, 4 http://www.biomedcentral.com/1472-6947/4/3
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linked to this register collects complete background infor-
mation on infertility and its treatment.
Even though the IVF children in the different data sources
were not the same children, most of the data in the two
routine IVF data sources were comparable to the IVF
research data. This suggests that drop-outs were not
selected by outcome. One likely explanation is that chil-
dren born after inseminations and ovulation inductions
with increased risk for adverse perinatal outcome may be
reported as IVF children in the MBR. Despite this draw-
back, our results give confidence that IVF services (IVF sta-
tistics) and most short-term infant outcomes of IVF
newborns (IVF statistics and the MBR) can be reliably
monitored in Finland without ad hoc data collection.
The existing routine Finnish data sources do not, however,
answer all relevant study questions, such as explaining the
variation in success rates by clinics in controlling for con-
founding factors. For these purposes, a nation-wide IVF
register would be useful. Furthermore, such a register
incorporating personal identification number would ena-
ble data linkages to other health outcome sources, for
example getting more accurate information on congenital
anomalies or to study the long-term health outcomes of
treated women and children born as a result of IVF
treatments.
The Finnish health information system is based on indi-
vidual-level register data with the unique personal identi-
fication number that is given to all Finnish citizens and
permanent residents. In general, the possibility to identify
each individual with certainty improves the quality of any
data collection and the utilisation of a single register, but
also enables technically easy data linkages between vari-
ous registers. There have been proposals to change the
national data protection legislation so that a launch of an
IVF register could be made possible [6,25], but the idea
has not been explored thoroughly. Close co-operation
between IVF clinics and the register-keeping organisation
is required to ensure high quality register data, to mini-
mise the extra work load in the IVF clinics and to protect
the privacy and confidentiality of treated women.
IVF is highly specialised care given by a limited number of
clinics, and therefore information can be gathered rela-
tively easily. The case is different for other infertility treat-
ments, since they are given more widely. Information on
certain surgical procedures has been collected in the Finn-
ish Hospital Discharge Register since 1986, but its use in
questions related to infertility treatments is challenged by
the limitations in the national classification on operative
interventions. Data on inseminations and ovulation
inductions has been collected for administrative purposes
on an aggregated level [26], and regionally as ad hoc clin-
ical information [27]. Since other infertility treatment
methods including ovulation induction may have similar
risks as IVF, it is important to monitor also these treat-
ments and their outcomes.
Conclusions
The existing two IVF data sets, which are routinely col-
lected by the Finnish health authorities, can be used in
monitoring of IVF services and their short-term outcomes
in general. Information on congenital anomalies as well
as on long-term outcome of treated women and IVF chil-
dren, however, has to be collected separately.
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